Small-angle X-ray scattering study of the ATP modulation of the structural features of the nucleotide binding domains of the CFTR in solution

European Biophysics Journal

Volumn 40, Issue 7, 2011, Pages 811-824

  Galeno, Lauretta ^a   Galfrè, Elena ^a   Moran, Oscar ^a  

^a CNR   (Italy)

Author keywords

ABC transporter; CFTR; Cystic fibrosis; Nucleotide binding domain; Protein structure; Protein protein interactions; X ray scattering

Indexed keywords

ADENOSINE TRIPHOSPHATE; TRANSMEMBRANE CONDUCTANCE REGULATOR;

ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY; DRUG EFFECT; HUMAN; METABOLISM; PROTEIN FOLDING; PROTEIN MULTIMERIZATION; PROTEIN QUATERNARY STRUCTURE; PROTEIN TERTIARY STRUCTURE; SMALL ANGLE SCATTERING; SOLUTION AND SOLUBILITY; X RAY DIFFRACTION;

ADENOSINE TRIPHOSPHATE; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; HUMANS; MODELS, MOLECULAR; PROTEIN FOLDING; PROTEIN MULTIMERIZATION; PROTEIN STRUCTURE, QUATERNARY; PROTEIN STRUCTURE, TERTIARY; SCATTERING, SMALL ANGLE; SOLUTIONS; X-RAY DIFFRACTION;

EID: 79959715752     PISSN: 01757571     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00249-011-0692-5     Document Type: Article

References (37)

1. Annereau JP, Wulbrand U, Vankeerberghen A, Cuppens H, Bontems F, Tümmler B, Cassiman JJ, Stoven V (1997) A novel model for the first nucleotide binding domain of the cystic fibrosis transmembrane conductance regulator. FEBS Lett 407:303-308 (Pubitemid 27199448)
2. Awayn NH, Rosenberg MF, Kamis AB, Aleksandrov LA, Riordan JR, Ford RC (2005) Crystallographic and single-particle analyses of native- and nucleotide-bound forms of the cystic fibrosis transmembrane conductance regulator (CFTR) protein. Biochem Soc Trans 33:996-999 (Pubitemid 41659098)
3. Csanády L, Nairn AC, Gadsby DC (2006) Thermodynamics of CFTR channel gating: a spreading conformational change initiates an irreversible gating cycle. J Gen Physiol 128:523-533 (Pubitemid 44664630)
4. Feigin LA, Svergun DI (1987) Structure analysis by small-angle X-ray and neutron scattering. Plenum Press, New York
5. Franke D, Svergun DI (2009) DAMMIF, a program for rapid ab initio shape determination in small-angle scattering. J Appl Cryst 42:342-346
6. Gadsby DC, Vergani P, Csanády L (2006) The ABC protein turned chloride channel whose failure causes cystic fibrosis. Nature 440:477-483
7. Glatter O, Kratky O (1982) Small angle X-ray scattering. Academic Press, London
8. Guinier A, Fournet G (1955) Small angle scattering of X-rays. Wiley, New York
9. Hartman J, Huang Z, Rado TA, Peng S, Jilling T, Muccio DD, Sorscher EJ (1992) Recombinant synthesis, purification, and nucleotide binding characteristics of the first nucleotide binding domain of the cystic fibrosis gene product. J Biol Chem 267:6455-6458
10. Karpowich N, Martsinkevich O, Millen L, Yuan YR, Dai PL, MacVey K, Thomas PJ, Hunt JF (2001) Crystal structures of the MJ1267 ATP binding cassette reveal an induced-fit effect at the ATPase active site of an ABC transporter. Structure 9:571-586 (Pubitemid 32695582)
11. Kidd JF, Ramjeesingh M, Stratford F, Huan LJ, Bear CE (2004) A heteromeric complex of the two nucleotide binding domains of cystic fibrosis transmembrane conductance regulator (CFTR) mediates ATPase activity. J Biol Chem 279:41664-41669 (Pubitemid 39313611)
12. Konarev P, Volkov VV, Sokolova AV, Koch MHJ, Svergun DI (2003) PRIMUS: a Windows PC-based system for small-angle scattering data analysis. J Appl Cryst 36:1277-1282
13. Kozin MB, Svergun DI (2001) Automated matching of high- and low-resolution structural models. J Appl Cryst 34:33-41 (Pubitemid 32151714)
14. Lewis HA, Zhao X, Wang C, Sauder JM, Rooney I, Noland BW, Lorimer D, Kearins MC, Conners K, Condon B, Maloney PC, Guggino WB, Hunt JF, Emtage S (2005) Impact of the DeltaF508 mutation in first nucleotide-binding domain of human cystic fibrosis transmembrane conductance regulator on domain folding and structure. J Biol Chem 280:1346-1353
15. Locher KP (2009) Structure and mechanism of ATP-binding cassette transporters. Philos Trans R Soc Lond B Biol Sci 364:239-245
16. Logan J, Hiestand D, Daram P, Huang Z, Muccio DD, Hartman J, Haley B, Cook WJ, Sorscher EJ (1994) Cystic fibrosis transmembrane conductance regulator mutations that disrupt nucleotide binding. J Clin Invest 94:228-236 (Pubitemid 24218096)
17. Lu NT, Pedersen PL (2000) Cystic fibrosis transmembrane conductance regulator: the purified NBF1+R protein interacts with the purified NBF2 domain to form a stable NBF1+R/NBF2 complex while inducing a conformational change transmitted to the Cterminal region. Arch Biochem Biophys 375:7-20 (Pubitemid 30133616)
18. Mense M, Vergani P, White DM, Altberg G, Nairn AC, Gadsby DC (2006) In vivo phosphorylation of CFTR promotes formation of a nucleotide-binding domain heterodimer. EMBO J 25:4728-4739
19. Mio K, Ogura T, Mio M, Shimizu H, Hwang T, Sato C, Sohma Y (2008) Three-dimensional reconstruction of human cystic fibrosis transmembrane conductance regulator chloride channel revealed an ellipsoidal structure with orifices beneath the putative transmembrane domain. J Biol Chem 283:30300-30310
20. Moran O, Galietta LJV, Zegarra-Moran O (2005) Binding site of activators of the cystic fibrosis transmembrane conductance regulator in the nucleotide binding domains. Cell Mol Life Sci 62:446-460 (Pubitemid 40379235)
21. Mornon J, Lehn P, Callebaut I (2009) Molecular models of the open and closed states of the whole human CFTR protein. Cell Mol Life Sci 66:3469-3486
22. Mylonas E, Svergun DI (2007) Accuracy of molecular mass determination of proteins in solution by small-angle X-ray scattering. J Appl Cryst 40:s245-s249 (Pubitemid 46732696)
23. Neville DC, Rozanas CR, Tulk BM, Townsend RR, Verkman AS (1998) Expression and characterization of the NBD1-R domain region of CFTR: evidence for subunit-subunit interactions. Biochemistry 37:2401-2409 (Pubitemid 28119315)
24. Qu BH, Strickland EH, Thomas PJ (1997) Localization and suppression of a kinetic defect in cystic fibrosis transmembrane conductance regulator folding. J Biol Chem 272:15739-15744 (Pubitemid 27265548)
25. Rosenberg MF, Kamis AB, Aleksandrov LA, Ford RC, Riordan JR (2004) Purification and crystallization of the cystic fibrosis transmembrane conductance regulator (CFTR). J Biol Chem 279:39051-39057 (Pubitemid 39296067)
26. Sharma S, Rose DR (1995) Cloning, overexpression, purification, and characterization of the carboxyl-terminal nucleotide binding domain of P-glycoprotein. J Biol Chem 270:14085-14093
27. Sreerama N, Woody RW (2004) Computation and analysis of protein circular dichroism spectra. Methods Enzymol 383:318-351 (Pubitemid 38401795)
28. Svergun DI (1992) Determination of the regularization parameter in indirect-transform methods using perceptual criteria. J Appl Cryst 25:495-503
29. Svergun DI (1999) Restoring low resolution structure of biological macromolecules from solution scattering using simulated annealing. Biophys J 76:2879-2886
30. Svergun DI, Koch MH (2003) Small-angle scattering studies of biological macromolecules in solution. Rep Prog Phys 66:1735-1782 (Pubitemid 37365734)
31. Thibodeau PH, Brautigam CA, Machius M, Thomas PJ (2005) Side chain and backbone contributions of Phe508 to CFTR folding. Nat Struct Mol Biol 12:10-16 (Pubitemid 40082911)
32. Vergani P, Nairn AC, Gadsby DC (2003) On the mechanism of MgATP-dependent gating of CFTR Cl- channels. J Gen Physiol 121:17-36 (Pubitemid 36133934)
33. Vergani P, Basso C, Mense M, Nairn AC, Gadsby DC (2005) Control of the CFTR channel's gates. Biochem Soc Trans 33:1003-1007 (Pubitemid 41659100)
34. Volkov V, Svergun D (2003) Uniqueness of ab initio shape determination in small-angle scattering. J Appl Cryst 36:860-864
35. Wriggers W (2010) Using Situs for the integration of multi-resolution structures. Biophys Rev 2:21-27
36. Wriggers W, Chacón P (2001) Using situs for the registration of protein structures with low-resolution bead models from X-ray solution scattering. J Appl Cryst 34:773-776 (Pubitemid 33144106)
37. Zegarra-Moran O, Monteverde M, Galietta LJV, Moran O (2007) Functional analysis of mutations in the putative binding site for cystic fibrosis transmembrane conductance regulator potentiators. Interaction between activation and inhibition. J Biol Chem 282:9098-9104 (Pubitemid 47093516)